Ajay Kumar Shukla et al. 2022. Ivermectin in Mild COVID-19: Panoramic Evaluation of the Evidence . Current Aspects in Pharmaceutical Research and Development Vol. 9. (Feb. 2022), 130–136. DOI:https://doi.org/10.9734/bpi/caprd/v9/15204D.